1. Home
  2. OLMA vs RBB Comparison

OLMA vs RBB Comparison

Compare OLMA & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • RBB
  • Stock Information
  • Founded
  • OLMA 2006
  • RBB 2008
  • Country
  • OLMA United States
  • RBB United States
  • Employees
  • OLMA N/A
  • RBB N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • RBB Major Banks
  • Sector
  • OLMA Health Care
  • RBB Finance
  • Exchange
  • OLMA Nasdaq
  • RBB Nasdaq
  • Market Cap
  • OLMA 383.1M
  • RBB 374.0M
  • IPO Year
  • OLMA 2020
  • RBB 2017
  • Fundamental
  • Price
  • OLMA $4.99
  • RBB $17.25
  • Analyst Decision
  • OLMA Strong Buy
  • RBB Hold
  • Analyst Count
  • OLMA 4
  • RBB 4
  • Target Price
  • OLMA $28.33
  • RBB $21.25
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • RBB 53.1K
  • Earning Date
  • OLMA 03-10-2025
  • RBB 02-03-2025
  • Dividend Yield
  • OLMA N/A
  • RBB 3.71%
  • EPS Growth
  • OLMA N/A
  • RBB N/A
  • EPS
  • OLMA N/A
  • RBB 1.47
  • Revenue
  • OLMA N/A
  • RBB $104,842,000.00
  • Revenue This Year
  • OLMA N/A
  • RBB N/A
  • Revenue Next Year
  • OLMA N/A
  • RBB $7.66
  • P/E Ratio
  • OLMA N/A
  • RBB $11.73
  • Revenue Growth
  • OLMA N/A
  • RBB N/A
  • 52 Week Low
  • OLMA $4.60
  • RBB $16.54
  • 52 Week High
  • OLMA $16.62
  • RBB $25.30
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 38.98
  • RBB 24.86
  • Support Level
  • OLMA $4.94
  • RBB $17.41
  • Resistance Level
  • OLMA $5.34
  • RBB $18.48
  • Average True Range (ATR)
  • OLMA 0.42
  • RBB 0.77
  • MACD
  • OLMA -0.03
  • RBB -0.03
  • Stochastic Oscillator
  • OLMA 11.39
  • RBB 2.35

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

Share on Social Networks: